Product Program year 2025 Source: CMS Open Payments

True Dilatation

Device Vascular/Oncology

PDI 00801741097553

Open in the dashboard

General payments

$1,099

33 payments

Research payments

$0

0 payments

Through program year 2025, $1,099 in general payments and $0 in research payments were reported against True Dilatation (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $181 7
2024 General $341 14
2023 General $577 12

Breakdown

Who paid General payments · program years 2023–2025
  1. Bard Peripheral Vascular, Inc. $912 26 payments
  2. Becton, Dickinson and Company $187 7 payments
Top recipients General payments · program year 2025
  1. Michael Simons Nurse Anesthetist, Certified Registered · Utica, NY $33 18% · 1 payment
  2. Tomasz Stys Interventional Cardiology · Sioux Falls, SD $33 18% · 1 payment
  3. Howard Herrmann Interventional Cardiology · Philadelphia, PA $25 14% · 1 payment
  4. Alexander Fanaroff Cardiovascular Disease · Philadelphia, PA $25 14% · 1 payment
  5. Jeremy Walter Nurse Practitioner, Acute Care · Philadelphia, PA $25 14% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $83 46% · 3 practitioners
  2. Cardiovascular Disease Internal Medicine $40 22% · 2 practitioners
  3. Nurse Anesthetist, Certified Registered $33 18% · 1 practitioner
  4. Nurse Practitioner, Acute Care Nurse Practitioner $25 14% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Pennsylvania $50 28% · 2 recipients
  2. Texas $40 22% · 2 recipients
  3. New York $33 18% · 1 recipient
  4. South Dakota $33 18% · 1 recipient
  5. North Carolina $25 14% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

33 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record